[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @A_May_MD Adam May Adam May posts on X about $abvx, $lly, $xbi, $qure the most. They currently have XXXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours. ### Engagements: XXXXXX [#](/creator/twitter::940047237240971264/interactions)  - X Week XXXXXXX -XXXX% - X Month XXXXXXXXX -XX% - X Months XXXXXXXXX +117% - X Year XXXXXXXXXX +599% ### Mentions: XX [#](/creator/twitter::940047237240971264/posts_active)  - X Week XX -XX% - X Month XXX -X% - X Months XXX +49% - X Year XXXXX +211% ### Followers: XXXXXX [#](/creator/twitter::940047237240971264/followers)  - X Week XXXXXX +0.62% - X Month XXXXXX +3.60% - X Months XXXXXX +133% - X Year XXXXXX +288% ### CreatorRank: XXXXXXX [#](/creator/twitter::940047237240971264/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) XXXXX% [finance](/list/finance) XXXX% [cryptocurrencies](/list/cryptocurrencies) XXXX% [countries](/list/countries) XXXX% **Social topic influence** [$abvx](/topic/$abvx) #12, [$lly](/topic/$lly) #165, [$xbi](/topic/$xbi) 7.46%, [$qure](/topic/$qure) #8, [$bbc](/topic/$bbc) 4.48%, [$ntla](/topic/$ntla) 4.48%, [$cdtx](/topic/$cdtx) #6, [$nvo](/topic/$nvo) #80, [$abbv](/topic/$abbv) #13, [acquisition](/topic/acquisition) #1396 **Top accounts mentioned or mentioned by** [@xanjvol](/creator/undefined) [@fwcweather](/creator/undefined) [@charle77238](/creator/undefined) [@houndcl](/creator/undefined) [@sanctuarybio](/creator/undefined) [@financebully](/creator/undefined) [@byebyegoodguy](/creator/undefined) [@pickingmyown](/creator/undefined) [@pawcio2009](/creator/undefined) [@2035bio](/creator/undefined) [@hannibalspeaks](/creator/undefined) [@gb21067283](/creator/undefined) [@biopharmiq](/creator/undefined) [@mm3915038575333](/creator/undefined) [@snupsnus](/creator/undefined) [@rjccapital](/creator/undefined) [@biotechobserver](/creator/undefined) [@plainyogurt21](/creator/undefined) [@bingbingbom](/creator/undefined) [@geneinvesting](/creator/undefined) **Top assets mentioned** [Eli Lilly and Company (LLY)](/topic/$lly) [Bitcoin Incognito (XBI)](/topic/$xbi) [uniQure N.V. (QURE)](/topic/$qure) [Intellia Therapeutics, Inc (NTLA)](/topic/$ntla) [Cidara Therapeutics, Inc. (CDTX)](/topic/$cdtx) [Novo-Nordisk (NVO)](/topic/$nvo) [AbbVie Inc (ABBV)](/topic/$abbv) [Janux Therapeutics, Inc. Common Stock (JANX)](/topic/$janx) [Kymera Therapeutics, Inc. Common Stock (KYMR)](/topic/$kymr) [Johnson & Johnson (JNJ)](/topic/$jnj) [Klaydice (DICE)](/topic/$dice) [MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)](/topic/$mltx) [Praxis Precision Medicines, Inc. Common Stock (PRAX)](/topic/$prax) [BridgeBio Pharma, Inc. Common Stock (BBIO)](/topic/$bbio) [Tarsus Pharmaceuticals, Inc. Common Stock (TARS)](/topic/$tars) [Insmed, Inc. (INSM)](/topic/$insm) [Pfizer, Inc. (PFE)](/topic/$pfe) [Metsera, Inc. Common Stock (MTSR)](/topic/$mtsr) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Bitcoin (BTC)](/topic/bitcoin) [Strategy (MSTR)](/topic/$mstr) [ARK Innovation ETF (ARKK)](/topic/$arkk) [Kiniksa Pharmaceuticals, Ltd. Class A Common Stock (KNSA)](/topic/$knsa) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Apogee Therapeutics, Inc. Common Stock (APGE)](/topic/$apge) ### Top Social Posts Top posts by engagements in the last XX hours "$VTYX delaying recurrent pericarditis (RP) data" [X Link](https://x.com/A_May_MD/status/1995828809506193836) 2025-12-02T12:14Z 19.1K followers, 11.4K engagements "Credit where its due - $NVO should bounce today. Those amycretin data look quite impressive at first glance. Weight loss and A1c target (7) rate were both better than not only semaglutide but somehow also tirzepatide (cross trial comparison caveat)" [X Link](https://x.com/A_May_MD/status/1993283660695617585) 2025-11-25T11:40Z 19.1K followers, 69.5K engagements "$NKTR down XX% in X sessions now. Seems likely that people dont want to be exposed to the impending AA readout. Expectations for that readout are very low and understandably so. Its historically been a very difficult to treat disease. Well know soon enough whether we can get on to focussing on just atopic derm or not" [X Link](https://x.com/A_May_MD/status/1995894259845595257) 2025-12-02T16:34Z 19.1K followers, 21.7K engagements "Actually laughed out loud while reading the $ABBV comments on $ABVX today. Frankly theyre ridiculous and the company shouldve stuck to the boilerplate we monitor all competitive drugs but are highly confident in the profile of our current programs drivel that pharma usually falls on. The concerns they highlighted just show how legitimately worried they are about $ABVX as a competitive threat (as they very well should be). No other large pharma gets a portion of its revenue from IBD as large as $ABBV does. Its their companys entire core. Furthermore no large pharma makes *less* sense as an" [X Link](https://x.com/A_May_MD/status/1996335203913027715) 2025-12-03T21:46Z 19.1K followers, 52.1K engagements "@2035Bio $JNJ is a front runner runner to go for $ABVX for sure. Of course $LLY has a $MORF sized hole that $ABVX could more than fill and Id bet my bottom dollar theyve got their own oral IL-23 program cooking from the $DICE acquisition as we speak" [X Link](https://x.com/A_May_MD/status/1996343442377781581) 2025-12-03T22:19Z 19.1K followers, 2152 engagements "My X cents on $MLTX is that the focus on bench/mechanistic science has to be trumped by clinical data. I actually think there was a *lot* of clinical data here to convince me that SLK was very clearly not superior to bime (though of course as I said even I didn't expect a total P3 *miss* so my approach didn't even get me to that point). First XX% and XX% for Bime's P3 trials is just not correct. It is a literal different endpoint All-ABX. We have to use the HS-ABX analysis that $MLTX used which for Bime translated to a XXXX% pooled rate across the X P3s (not the XXXX% that people erroneously" [X Link](https://x.com/A_May_MD/status/1972489903683285064) 2025-09-29T02:33Z 19K followers, 28.8K engagements "When drugs start working in neuro conditions that drugs dont work in $QURE $PRAX" [X Link](https://x.com/A_May_MD/status/1978789102053912775) 2025-10-16T11:44Z 19K followers, 33.7K engagements "Also excluding the COVID vaccines Im pretty sure the industry just had its first ever $10B/quarter drug $LLY" [X Link](https://x.com/A_May_MD/status/1983859375157424274) 2025-10-30T11:31Z 19K followers, 8218 engagements "10 months later this has become the biotech mantra. "Short the launch" was a strong and successful approach for years.Now companies like $BBIO $VRNA $TARS and $INSM are just destroying that narrative. #LaunchTheShorts $XBI $BBC" [X Link](https://x.com/A_May_MD/status/1983861411731423289) 2025-10-30T11:39Z 19K followers, 23.3K engagements "Denmark preparing to mobilize its North American Expeditionary Mergers & Acquisitions Force to the $PFE front in NY while concurrently monitoring the $LLY front's quarterly intelligence briefing coming out of Indianapolis this morning. Trump admin preparing federal funding to boost $PFE's $MTSR CVR offer in gambit to undermine Danish position in Greenland. $NVO" [X Link](https://x.com/A_May_MD/status/1983882303165088189) 2025-10-30T13:02Z 19.1K followers, 49.9K engagements "OkIll bite. Whats going on with $ABVX" [X Link](https://x.com/A_May_MD/status/1983891943156293739) 2025-10-30T13:41Z 19.1K followers, 63.1K engagements "So back. $XBI $BBC" [X Link](https://x.com/A_May_MD/status/1983894754317230497) 2025-10-30T13:52Z 19K followers, 9794 engagements "@bingbingbom @Sanctuary_Bio Wait @bingbingbom are you suggesting that @GeneInvesting (AKA $NTLA plasma guy) tried to run over a sexual assault victims parents with his car Thats crazy if its true. Psychotic behavior. Nobody could have ever known he was like that" [X Link](https://x.com/A_May_MD/status/1987911400610840874) 2025-11-10T15:53Z 19K followers, 4481 engagements "Pretty sure $LLY Dave Ricks just told me to lever up on small cap biotechs 🤷🏻♂ $XBI 🚀" [X Link](https://x.com/A_May_MD/status/1988366686957764733) 2025-11-11T22:02Z 19K followers, 22.1K engagements "Pretty sure $LLY Dave Ricks just told me to dump $VKTX 🤷🏻♂" [X Link](https://x.com/A_May_MD/status/1988368395210027507) 2025-11-11T22:09Z 19K followers, 14.9K engagements "@GeneInvesting When $XBI has a face ripping rally day like yesterday and $NTLA just market performs (not up double digit % like a high beta name should be on such days) you know its in trouble. Tick tock $NTLA. Going lower" [X Link](https://x.com/A_May_MD/status/1988632441888649718) 2025-11-12T15:38Z 19K followers, 28.9K engagements "$CDTX buyout rumor per FT. Believe it. Biotech is absolutely on fire $XBI $BBC" [X Link](https://x.com/A_May_MD/status/1989117043111784756) 2025-11-13T23:43Z 19K followers, 39.1K engagements "First of all props to the author of this first time biotech write up on $QURE. It takes a lot of time and courage to put your stuff out there but it is an unrivaled way to learn. Now there are several things I disagree with in the article so I'll do my part and perhaps contribute to some of that learning (as I trust others will continue to do for me). X One big thing the author already corrected in the article was the narrative that $QURE has hidden sham-controlled data or designed this study in a misleading way. This is not the case whatsoever but I have seen the sentiment pop up several" [X Link](https://x.com/A_May_MD/status/1990432588457009606) 2025-11-17T14:51Z 19K followers, 143.7K engagements "Cathie and Mike are going to be duking it out over the title for Most investor value ever destroyed. Incredible to witness. $ARKK $ARKG $BTC $MSTR" [X Link](https://x.com/A_May_MD/status/1991883198465470727) 2025-11-21T14:55Z 19K followers, 24.6K engagements "@Anders_Research Ive seen people wonder why $KNSA seems to trade at such a low multiple to its peak sales trajectory. I think patent security is the likely answer" [X Link](https://x.com/A_May_MD/status/1992723226389352518) 2025-11-23T22:33Z 19K followers, XXX engagements "@junktradeaim @bioinvestor24 @Justin_McD01 Dumped to to short $NTLA" [X Link](https://x.com/A_May_MD/status/1993403886728847443) 2025-11-25T19:38Z 19K followers, 1251 engagements "@basadomente As I repeatedly say I want $ABVX to wait for a post maintenance or even post Crohns buyoutBut a pharma sure could make a splash and put $ABBV in their targets by showing up to JPM with $ABVX in their pocket this January" [X Link](https://x.com/A_May_MD/status/1996337740288291229) 2025-12-03T21:56Z 19K followers, 2764 engagements "$PALI further proving its legitimacy by bringing Sharon Skare on board as VP of clinical operations. She previously served in the same role in the same disease (IBD) at ➡ $ARNA - bought out for $6.7B after phase X data ➡ $ABVX - currently $7B likely to be bought out (***in my biased opinion***) north of $10B after phase X data $PALIs valuation remains cheap IMO continuing to reflect skepticism about the PDE4 MoA in UC. Years ago I watched these ex-$ARNA employees joining another tiny IBD company whose drug the market was *very* skeptical of.that was $ABVX. Still early days for $PALI but" [X Link](https://x.com/A_May_MD/status/1983527323044356327) 2025-10-29T13:32Z 19.1K followers, 71.3K engagements "Pains me to say it but.I have shorted $JANX after hours. Sure PSA responses got worse - they almost had to with how good they looked in the n=16. But ORR and mPFS are just not good. I strongly suspect that in a big pharma's hands they wouldn't even take this program forward. Not enough responses and not durable enough when they happen (what's the cORR by the way). Probably belongs right around cash ($17/share) where $VIR already trades. Maybe even below cash unfortunately. PSMA was supposed to be their ticket.EGFR has always been talked down. IMO it looks like the flagship is going down." [X Link](https://x.com/A_May_MD/status/1995612379543994877) 2025-12-01T21:54Z 19.1K followers, 56K engagements "Imagine selling $ABVX when there are bidding wars like this going on 😅" [X Link](https://x.com/A_May_MD/status/1997093067929653622) 2025-12-05T23:57Z 19.1K followers, 41.5K engagements "Fully diluted $KYMR traded above a $10B market cap today *before* this offering. P1b open label data n30. 🤷🏻♂ 🫡" [X Link](https://x.com/A_May_MD/status/1998142589640515789) 2025-12-08T21:28Z 19.1K followers, 62.5K engagements "@Steptradez Idk if Id go that far but between $KYMR and $APGE there sure is a lot of $$$ being fed into more convenient dupixent me-toos. Like $15B between these two P1-P2 companies" [X Link](https://x.com/A_May_MD/status/1998143081166815431) 2025-12-08T21:30Z 19.1K followers, 3653 engagements "@XanjVol @Gb21067283 Oooooohhhhhhh the MMs randomly decided to light X million dollars on fire for no reason this afternoon got it. Interesting business model" [X Link](https://x.com/A_May_MD/status/1998560150542758090) 2025-12-10T01:07Z 19.1K followers, 2171 engagements "Absolutely BRTUAL of the FDA to change their stance on the $QURE trial design *after* the study has run for X years. If you thought there was public backlash for $REPL with their relapsed/refractory melanoma population buckle up.Because Huntington's disease docs patients and patient support groups are about the absolutely flip out.understandably so" [X Link](https://x.com/A_May_MD/status/1985324011757179179) 2025-11-03T12:31Z 19.1K followers, 154.3K engagements "I have been buying the $QURE dip. This morning's press release was a calculated decision by $QURE management. Note that there's a key word in the press release that I have not seen people discussing."BELIEVES". $QURE has not yet received formal word that they cannot submit for approval but $QURE "BELIEVES" that the FDA is no longer going to accept the plan they had previously agreed to. $QURE is under no obligation to release their guesses as to regulatory decisions. So why would they make a press release like this that tanks their stock Why not wait for the official word to actually come in" [X Link](https://x.com/A_May_MD/status/1985364073001656611) 2025-11-03T15:10Z 19.1K followers, 200.6K engagements "$155 for $CDTX was the stab in the dark guess of a man who was deeply scarred by the last X years of vicious biotech bear market 😅 That said the actual bid of $XXXXXX is an INCREDIBLE premium for $CDTX. Biotech M&A is on the hottest streak Ive ever seen not only in terms of volume of deals but also the premiums they are fetching. Consensus M&A names are going like hotcakes and literal post-tender offer bidding wars are erupting ( $MTSR and now $AVDL today) Those have always seemed like a myth/legend to me and we have been in X of them this month alone Ive never seen this in biotech. I might" [X Link](https://x.com/A_May_MD/status/1989321682662592988) 2025-11-14T13:17Z 19.1K followers, 61K engagements "@XanjVol @Gb21067283 You actually think nobody looked for an opposite side hedge to this trade Thats the first thing everyone did. None there" [X Link](https://x.com/A_May_MD/status/1998560518311952534) 2025-12-10T01:08Z 19.1K followers, 1743 engagements "@XanjVol @Gb21067283 A spread has X legs. Wheres the 2nd leg" [X Link](https://x.com/A_May_MD/status/1998562100969615445) 2025-12-10T01:15Z 19.1K followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@A_May_MD Adam MayAdam May posts on X about $abvx, $lly, $xbi, $qure the most. They currently have XXXXXX followers and XX posts still getting attention that total XXXXXX engagements in the last XX hours.
Social category influence stocks XXXXX% finance XXXX% cryptocurrencies XXXX% countries XXXX%
Social topic influence $abvx #12, $lly #165, $xbi 7.46%, $qure #8, $bbc 4.48%, $ntla 4.48%, $cdtx #6, $nvo #80, $abbv #13, acquisition #1396
Top accounts mentioned or mentioned by @xanjvol @fwcweather @charle77238 @houndcl @sanctuarybio @financebully @byebyegoodguy @pickingmyown @pawcio2009 @2035bio @hannibalspeaks @gb21067283 @biopharmiq @mm3915038575333 @snupsnus @rjccapital @biotechobserver @plainyogurt21 @bingbingbom @geneinvesting
Top assets mentioned Eli Lilly and Company (LLY) Bitcoin Incognito (XBI) uniQure N.V. (QURE) Intellia Therapeutics, Inc (NTLA) Cidara Therapeutics, Inc. (CDTX) Novo-Nordisk (NVO) AbbVie Inc (ABBV) Janux Therapeutics, Inc. Common Stock (JANX) Kymera Therapeutics, Inc. Common Stock (KYMR) Johnson & Johnson (JNJ) Klaydice (DICE) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) Praxis Precision Medicines, Inc. Common Stock (PRAX) BridgeBio Pharma, Inc. Common Stock (BBIO) Tarsus Pharmaceuticals, Inc. Common Stock (TARS) Insmed, Inc. (INSM) Pfizer, Inc. (PFE) Metsera, Inc. Common Stock (MTSR) Viking Therapeutics, Inc (VKTX) Bitcoin (BTC) Strategy (MSTR) ARK Innovation ETF (ARKK) Kiniksa Pharmaceuticals, Ltd. Class A Common Stock (KNSA) Cytokinetics Inc. (CYTK) Merck & Co., Inc. (MRK) Apogee Therapeutics, Inc. Common Stock (APGE)
Top posts by engagements in the last XX hours
"$VTYX delaying recurrent pericarditis (RP) data"
X Link 2025-12-02T12:14Z 19.1K followers, 11.4K engagements
"Credit where its due - $NVO should bounce today. Those amycretin data look quite impressive at first glance. Weight loss and A1c target (7) rate were both better than not only semaglutide but somehow also tirzepatide (cross trial comparison caveat)"
X Link 2025-11-25T11:40Z 19.1K followers, 69.5K engagements
"$NKTR down XX% in X sessions now. Seems likely that people dont want to be exposed to the impending AA readout. Expectations for that readout are very low and understandably so. Its historically been a very difficult to treat disease. Well know soon enough whether we can get on to focussing on just atopic derm or not"
X Link 2025-12-02T16:34Z 19.1K followers, 21.7K engagements
"Actually laughed out loud while reading the $ABBV comments on $ABVX today. Frankly theyre ridiculous and the company shouldve stuck to the boilerplate we monitor all competitive drugs but are highly confident in the profile of our current programs drivel that pharma usually falls on. The concerns they highlighted just show how legitimately worried they are about $ABVX as a competitive threat (as they very well should be). No other large pharma gets a portion of its revenue from IBD as large as $ABBV does. Its their companys entire core. Furthermore no large pharma makes less sense as an"
X Link 2025-12-03T21:46Z 19.1K followers, 52.1K engagements
"@2035Bio $JNJ is a front runner runner to go for $ABVX for sure. Of course $LLY has a $MORF sized hole that $ABVX could more than fill and Id bet my bottom dollar theyve got their own oral IL-23 program cooking from the $DICE acquisition as we speak"
X Link 2025-12-03T22:19Z 19.1K followers, 2152 engagements
"My X cents on $MLTX is that the focus on bench/mechanistic science has to be trumped by clinical data. I actually think there was a lot of clinical data here to convince me that SLK was very clearly not superior to bime (though of course as I said even I didn't expect a total P3 miss so my approach didn't even get me to that point). First XX% and XX% for Bime's P3 trials is just not correct. It is a literal different endpoint All-ABX. We have to use the HS-ABX analysis that $MLTX used which for Bime translated to a XXXX% pooled rate across the X P3s (not the XXXX% that people erroneously"
X Link 2025-09-29T02:33Z 19K followers, 28.8K engagements
"When drugs start working in neuro conditions that drugs dont work in $QURE $PRAX"
X Link 2025-10-16T11:44Z 19K followers, 33.7K engagements
"Also excluding the COVID vaccines Im pretty sure the industry just had its first ever $10B/quarter drug $LLY"
X Link 2025-10-30T11:31Z 19K followers, 8218 engagements
"10 months later this has become the biotech mantra. "Short the launch" was a strong and successful approach for years.Now companies like $BBIO $VRNA $TARS and $INSM are just destroying that narrative. #LaunchTheShorts $XBI $BBC"
X Link 2025-10-30T11:39Z 19K followers, 23.3K engagements
"Denmark preparing to mobilize its North American Expeditionary Mergers & Acquisitions Force to the $PFE front in NY while concurrently monitoring the $LLY front's quarterly intelligence briefing coming out of Indianapolis this morning. Trump admin preparing federal funding to boost $PFE's $MTSR CVR offer in gambit to undermine Danish position in Greenland. $NVO"
X Link 2025-10-30T13:02Z 19.1K followers, 49.9K engagements
"OkIll bite. Whats going on with $ABVX"
X Link 2025-10-30T13:41Z 19.1K followers, 63.1K engagements
"So back. $XBI $BBC"
X Link 2025-10-30T13:52Z 19K followers, 9794 engagements
"@bingbingbom @Sanctuary_Bio Wait @bingbingbom are you suggesting that @GeneInvesting (AKA $NTLA plasma guy) tried to run over a sexual assault victims parents with his car Thats crazy if its true. Psychotic behavior. Nobody could have ever known he was like that"
X Link 2025-11-10T15:53Z 19K followers, 4481 engagements
"Pretty sure $LLY Dave Ricks just told me to lever up on small cap biotechs 🤷🏻♂ $XBI 🚀"
X Link 2025-11-11T22:02Z 19K followers, 22.1K engagements
"Pretty sure $LLY Dave Ricks just told me to dump $VKTX 🤷🏻♂"
X Link 2025-11-11T22:09Z 19K followers, 14.9K engagements
"@GeneInvesting When $XBI has a face ripping rally day like yesterday and $NTLA just market performs (not up double digit % like a high beta name should be on such days) you know its in trouble. Tick tock $NTLA. Going lower"
X Link 2025-11-12T15:38Z 19K followers, 28.9K engagements
"$CDTX buyout rumor per FT. Believe it. Biotech is absolutely on fire $XBI $BBC"
X Link 2025-11-13T23:43Z 19K followers, 39.1K engagements
"First of all props to the author of this first time biotech write up on $QURE. It takes a lot of time and courage to put your stuff out there but it is an unrivaled way to learn. Now there are several things I disagree with in the article so I'll do my part and perhaps contribute to some of that learning (as I trust others will continue to do for me). X One big thing the author already corrected in the article was the narrative that $QURE has hidden sham-controlled data or designed this study in a misleading way. This is not the case whatsoever but I have seen the sentiment pop up several"
X Link 2025-11-17T14:51Z 19K followers, 143.7K engagements
"Cathie and Mike are going to be duking it out over the title for Most investor value ever destroyed. Incredible to witness. $ARKK $ARKG $BTC $MSTR"
X Link 2025-11-21T14:55Z 19K followers, 24.6K engagements
"@Anders_Research Ive seen people wonder why $KNSA seems to trade at such a low multiple to its peak sales trajectory. I think patent security is the likely answer"
X Link 2025-11-23T22:33Z 19K followers, XXX engagements
"@junktradeaim @bioinvestor24 @Justin_McD01 Dumped to to short $NTLA"
X Link 2025-11-25T19:38Z 19K followers, 1251 engagements
"@basadomente As I repeatedly say I want $ABVX to wait for a post maintenance or even post Crohns buyoutBut a pharma sure could make a splash and put $ABBV in their targets by showing up to JPM with $ABVX in their pocket this January"
X Link 2025-12-03T21:56Z 19K followers, 2764 engagements
"$PALI further proving its legitimacy by bringing Sharon Skare on board as VP of clinical operations. She previously served in the same role in the same disease (IBD) at ➡ $ARNA - bought out for $6.7B after phase X data ➡ $ABVX - currently $7B likely to be bought out (in my biased opinion) north of $10B after phase X data $PALIs valuation remains cheap IMO continuing to reflect skepticism about the PDE4 MoA in UC. Years ago I watched these ex-$ARNA employees joining another tiny IBD company whose drug the market was very skeptical of.that was $ABVX. Still early days for $PALI but"
X Link 2025-10-29T13:32Z 19.1K followers, 71.3K engagements
"Pains me to say it but.I have shorted $JANX after hours. Sure PSA responses got worse - they almost had to with how good they looked in the n=16. But ORR and mPFS are just not good. I strongly suspect that in a big pharma's hands they wouldn't even take this program forward. Not enough responses and not durable enough when they happen (what's the cORR by the way). Probably belongs right around cash ($17/share) where $VIR already trades. Maybe even below cash unfortunately. PSMA was supposed to be their ticket.EGFR has always been talked down. IMO it looks like the flagship is going down."
X Link 2025-12-01T21:54Z 19.1K followers, 56K engagements
"Imagine selling $ABVX when there are bidding wars like this going on 😅"
X Link 2025-12-05T23:57Z 19.1K followers, 41.5K engagements
"Fully diluted $KYMR traded above a $10B market cap today before this offering. P1b open label data n30. 🤷🏻♂ 🫡"
X Link 2025-12-08T21:28Z 19.1K followers, 62.5K engagements
"@Steptradez Idk if Id go that far but between $KYMR and $APGE there sure is a lot of $$$ being fed into more convenient dupixent me-toos. Like $15B between these two P1-P2 companies"
X Link 2025-12-08T21:30Z 19.1K followers, 3653 engagements
"@XanjVol @Gb21067283 Oooooohhhhhhh the MMs randomly decided to light X million dollars on fire for no reason this afternoon got it. Interesting business model"
X Link 2025-12-10T01:07Z 19.1K followers, 2171 engagements
"Absolutely BRTUAL of the FDA to change their stance on the $QURE trial design after the study has run for X years. If you thought there was public backlash for $REPL with their relapsed/refractory melanoma population buckle up.Because Huntington's disease docs patients and patient support groups are about the absolutely flip out.understandably so"
X Link 2025-11-03T12:31Z 19.1K followers, 154.3K engagements
"I have been buying the $QURE dip. This morning's press release was a calculated decision by $QURE management. Note that there's a key word in the press release that I have not seen people discussing."BELIEVES". $QURE has not yet received formal word that they cannot submit for approval but $QURE "BELIEVES" that the FDA is no longer going to accept the plan they had previously agreed to. $QURE is under no obligation to release their guesses as to regulatory decisions. So why would they make a press release like this that tanks their stock Why not wait for the official word to actually come in"
X Link 2025-11-03T15:10Z 19.1K followers, 200.6K engagements
"$155 for $CDTX was the stab in the dark guess of a man who was deeply scarred by the last X years of vicious biotech bear market 😅 That said the actual bid of $XXXXXX is an INCREDIBLE premium for $CDTX. Biotech M&A is on the hottest streak Ive ever seen not only in terms of volume of deals but also the premiums they are fetching. Consensus M&A names are going like hotcakes and literal post-tender offer bidding wars are erupting ( $MTSR and now $AVDL today) Those have always seemed like a myth/legend to me and we have been in X of them this month alone Ive never seen this in biotech. I might"
X Link 2025-11-14T13:17Z 19.1K followers, 61K engagements
"@XanjVol @Gb21067283 You actually think nobody looked for an opposite side hedge to this trade Thats the first thing everyone did. None there"
X Link 2025-12-10T01:08Z 19.1K followers, 1743 engagements
"@XanjVol @Gb21067283 A spread has X legs. Wheres the 2nd leg"
X Link 2025-12-10T01:15Z 19.1K followers, XXX engagements
/creator/twitter::A_May_MD